Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER maintenance treatment after acute manic or mixed episode in bipolar I disorder
2006-000846-38Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Paliperidone ER maintenance, Olanzapine active control and Placebo control (3 arms). Primary endpoints: Time to first recurrence of any mood symptoms associated with Bipolar I Disorder and Prevention of manic symptoms associated with Bipolar I Disorder. Started Sep 2006; status: completed.
02
Drugs
paliperidoneolanzapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2006-000846-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000846-38.